European Association for the Study of Diabetes
European Association for the Study of Diabetes
September 26, 2013
1 min read

Education improved outcomes after transition from pediatric to adult care

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

An education program geared toward patients with type 1 diabetes transitioning from pediatric to adult care yielded improvements in glycemic control, diabetes self-management and quality of life, according to data presented at EASD 2013.

Researchers evaluated the 12-month effects of a specially designed transition therapeutic education program on 189 patients aged about 18 years with type 1 diabetes transferring from pediatric to adult care units. The program consisted of a coordinated transfer from a pediatric to adult diabetes unit, individual visits and group sessions.

At 12 months, HbA1c decreased from 8.6% at baseline to 8% (P=.02), according to the abstract. The researchers also found a decrease in hypoglycemic episodes from 0.31 severe events per patient per year to 0.07 (P<.001), and the frequency of more than five mild episodes per week declined from 9.4% to 6.5% (P=.04).

Results revealed an increase from 25 to 27.7 in scores on a knowledge of diabetes management test (P=.04). Frequency of self-monitoring of blood glucose also rose from 20.5 to 22.7 determinations per week (P<.01). According to a self-reported questionnaire, improvement in worrying about diabetes-related issues was also associated with the education program.

“The use of a specific transition [therapeutic education program] improves metabolic control, self-management abilities and some aspects of diabetes-related [quality of life] of young [type 1 diabetes] subjects transferred from pediatric care to an adult diabetes unit,” the researchers wrote.

For more information:

Giménez M. P-1127. Presented at: the 49th Annual Meeting of the European Association for the Study of Diabetes; Sept. 24-27, 2013; Barcelona, Spain.

Disclosure: Endocrine Today could not confirm financial disclosures at this time.